Cell Signal 2004,
PMID: 15337530
Kim, Sung-Eun; Cho, Jae-Young; Kim, Kyung-Sup; Lee, Su-Jae; Lee, Ki-Hoo; Choi, Kang-Yell
We have characterized the role of Drosophila PI3K and AKT in ERK pathway activation involving insulin-induced proliferation using Drosophila Schneider cells. After insulin treatment, dPI3K and dAKT activities were both increased along with activation of the dERK pathway components dMEK and dERK. The insulin-induced activations of dERK and dAKT were blocked by LY294002, dPTEN, and by an AKT inhibitor, indicating involvement of dPI3K and dAKT in the insulin-induced dERK and dAKT activations. Proliferation and the G1 to S phase cell cycle progression due to insulin were also blocked by PI3K and AKT inhibitors, indicating that the Drosophila PI3K-AKT pathway involves insulin-mediated cell proliferation. The insulin-stimulated size increase was blocked by both LY294002 and AKT inhibitor, not by U0126, indicating that insulin-mediated size control by dPI3K and dAKT occurs independently of the ERK pathway. This study indicates that dPI3K and dAKT are involved in insulin-induced ERK pathway activation leading to proliferation in Drosophila Schneider cells.
Document information provided by NCBI PubMed
Text Mining Data
ERK → insulin: "
Drosophila PI3 kinase and Akt involved in
insulin stimulated proliferation and
ERK pathway activation in Schneider cells
"
ERK ⊣ AKT: "
We have characterized the role of Drosophila PI3K and AKT in ERK pathway activation involving insulin induced proliferation using Drosophila Schneider cells
"
ERK ⊣ PI3K: "
We have characterized the role of Drosophila PI3K and AKT in ERK pathway activation involving insulin induced proliferation using Drosophila Schneider cells
"
ERK → insulin: "
This study indicates that dPI3K and dAKT are involved in insulin induced ERK pathway activation leading to proliferation in Drosophila Schneider cells
"
Manually curated Databases
No curated data.